St. Jude Foresees Close-Out Letter Soon
This article was originally published in The Silver Sheet
St. Jude Medical says FDA has completed a re-inspection of its Sylmar, Calif., cardiac rhythm management device facility that drew an FDA warning letter in 2013, and it remains on track to have the letter closed out this year.
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.